BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
about
First Universities Allied for Essential Medicines (UAEM) Neglected Diseases and Innovation SymposiumRapid, serial, non-invasive assessment of drug efficacy in mice with autoluminescent Mycobacterium ulcerans infectionAccelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans diseaseEfficacy of Rifampin Plus Clofazimine in a Murine Model of Mycobacterium ulcerans DiseaseCellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.Buruli ulcer.Mycobacterium ulcerans Disease with Unusual Sites Not to Be IgnoredMicrobiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans diseaseTreating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?Use of Recombinant Virus Replicon Particles for Vaccination against Mycobacterium ulcerans Disease.Recombinant BCG Expressing Mycobacterium ulcerans Ag85A Imparts Enhanced Protection against Experimental Buruli ulcer.Interferon-γ Is a Crucial Activator of Early Host Immune Defense against Mycobacterium ulcerans Infection in Mice.Overexpression of a Mycobacterium ulcerans Ag85B-EsxH Fusion Protein in Recombinant BCG Improves Experimental Buruli Ulcer Vaccine EfficacyHistory, biology and chemistry of Mycobacterium ulcerans infections (Buruli ulcer disease).FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer.BCG and protection against inflammatory and auto-immune diseases.Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer
P2860
Q28478606-36520F27-FB6F-460B-8F85-9AC18806AFCBQ28537749-604B74EB-5878-4956-879A-2DB1A0C7D576Q28538259-D123CCF4-D192-46A4-BB5E-08727EF9C66AQ28552524-DE70A5A2-1A75-4A02-9857-0635342D8FA0Q34193844-CA4B2C0E-03A4-4489-8931-8C87557C0684Q34229628-57430FFF-A86A-44AE-BA93-14A6739CCAE9Q34438022-57257021-332A-4615-94CD-A9DF967C9B0BQ34630531-166D57E6-5575-4DB3-9DFA-4B9E2010F4E2Q35625819-0B2D92AE-DCD0-4D83-BED0-C169F2D6A508Q35746584-69F8BD87-7C7D-4EA8-BA8E-305776F7CDADQ35782951-1DB0F57B-60EC-44DB-A644-DDCA5DE87833Q35919532-E5941AD6-6A61-4731-8382-0D116870CAEAQ36219941-D8C42C77-1351-4D74-B3E4-BFDEECF4876EQ38157768-6BC0A1B3-FF23-44FB-B870-2CBF8D1307D3Q39215467-036A907F-27FC-4794-849D-BC52A4A87B6AQ40203403-59EAB03C-CC1B-4A06-9F18-4787E533C6D1Q58785246-24133036-B91A-4318-9D34-C6D1186BD92A
P2860
BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
@ast
BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
@en
type
label
BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
@ast
BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
@en
prefLabel
BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
@ast
BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
@en
P2093
P2860
P1476
BCG-mediated protection against Mycobacterium ulcerans infection in the mouse.
@en
P2093
Deepak V Almeida
Eric L Nuermberger
Jacques H Grosset
Paul J Converse
P2860
P356
10.1371/JOURNAL.PNTD.0000985
P407
P577
2011-03-15T00:00:00Z